SCHEMBL17376532

SCHEMBL17376532

O=[N+]([O-])c1c(O)nc(C2CC2)nc1C1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM3 P20309 1/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.36
▸ RAB9A P51151 2/20 0.35
▸ CCNA2 P20248 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ CCNA1 P78396 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ GABBR2 O75899 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ GABBR1 Q9UBS5 1/20 0.32
▸ FFAR2 O15552 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759384 0.84 CHRM3 (0.41) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL17376370 0.82 CHRM3 (0.40) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL27952825 0.69 CDK2 (0.55) RAB9ACCNA2CDK2CCNA1KMT2A
SCHEMBL8078173 0.67 KMT2A (0.34) RAB9ACCNA2CDK2CCNA1KMT2A
SCHEMBL1759440 0.66 PDE10A (0.50) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL27869897 0.65 CHRM3 (0.46) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL21306244 0.65 CHRM3 (0.36) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL11733107 0.64 RAB9A (0.37) HSP90AA1RAB9ACYP1A2ALDH1A1MAPT
SCHEMBL2571631 0.64 HSP90AA1 (0.36) HSP90AA1RAB9AKMT2AMEN1TDP1
SCHEMBL4428463 0.63 PDE10A (0.45) CHRM3PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106488919-B 3-substituted 2-aminoindole derivatives 武田药品工业株式会社 2018-10-23 — — CN disclosed
US-10059713-B2 3-substituted 2-amino-indole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-08-28 — — US disclosed
US-20170158700-A1 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES TAKEDA CAMBRIDGE LIMITED (GB) 2017-06-08 — — US disclosed
US-20170158700-A1 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES TAKEDA CAMBRIDGE LIMITED (GB) 2017-06-08 — — US disclosed
US-20170158700-A1 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES TAKEDA CAMBRIDGE LIMITED (GB) 2017-06-08 — — US disclosed
EP-3160965-A1 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES Takeda Pharmaceutical Company Limited (JP) 2017-05-03 — — EP disclosed
CN-106488919-A 3-substituted 2-aminoindole derivatives 武田药品工业株式会社 2017-03-08 — — CN disclosed
WO-2015198045-A1 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-12-30 — — WO disclosed
WO-2015198045-A1 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-12-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10059713-B2 3-substituted 2-amino-indole derivatives NPY5R, XDH, NPY4R CHRM3 91/4885PDE4A 550/4885PDE4B 373/4885
US-20170158700-A1 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES NPY5R, XDH, NPY4R CHRM3 91/4885PDE4A 550/4885PDE4B 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback